Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.24.10.0294 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Antônio A Beck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Equine Veterinary Teaching Hospital, College of Veterinary Medicine, Federal University of Santa Maria, Santa Maria, RS, Brazil. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Lameness, Animal, Horse Diseases, Osteoarthritis. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effect of IA injections of botulinum toxin type A (BoNT-A) in horses with chronic, naturally occurring distal tarsal osteoarthritis.
Methods
9 horses were selected after physical and radiographic assessments. Horses also underwent an objective lameness examination and were included if they had a hindlimb impact lameness (Pmin ≥ 3 mm), which positively responded (≥ 50%) to the tarsometatarsal and centrodistal joints’ anesthetic block. Horses randomly received an intra-articular injection of BoNT-A or an equivalent volume of saline solution. Horses were reevaluated at postinjection days (PIDs) 1, 7, 15, 30, 60, 90, 120, 150, and 180. Success criteria included a decrease in Pmin (≤ 3 mm) or an abolishment of lameness on the baseline lame limb with lameness shifting to the contralateral limb. A percentage of lameness improvement was calculated for all horses at all timepoints.
Results
5 horses were included in the BoNT-A group, whereas 4 individuals were allocated in the placebo group. A significant improvement ( P < .05) was observed in horses from the BoNT-A group when compared to placebo at PIDs 90, 120, 150, and 180. Two of 5 horses (40%) from the BoNT-A group had an absolute improvement (100%) in lameness at all the timepoints. Higher percentages of lameness improvement were observed at PID 60.
Conclusions
The results of this study suggest that the intra-articular injection with 50 U of BoNT-A was effective in reducing lameness in horses with distal tarsal osteoarthritis, mainly 90 days after injection. Clinical Relevance Botulinum toxin type A can be considered as an option for managing horses with chronic osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Equine Veterinary Teaching Hospital, College of Veterinary Medicine, Federal University of Santa Maria, Santa Maria, RS, Brazil.
- Marion duPont Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, Leesburg, VA.
- Department of Large Animal Clinics, College of Veterinary Medicine, Federal University of Santa Maria, Santa Maria, RS, Brazil.
ORCID-Profile: Antônio A Beck
Zitieren
APA
Beck, A. A., Paz, L. B., Frank, M. I., Pereira, R. C. F., & De La Côrte, F. D. (2025). Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.10.0294
Vancouver
Beck AA, Paz LB, Frank MI, Pereira RCF, De La Côrte FD. Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.24.10.0294
BibTeX
@article{Beck2025,
author = {Beck, Antônio A and Paz, Letícia B and Frank, Maria I and Pereira, Roberta C F and De La Côrte, Flávio D},
title = {Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.24.10.0294}
}
EUVIMED